Literature DB >> 21191189

Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity.

Wan Zhang1, Peng Huang.   

Abstract

It has been known for a long time that the interaction between cancer cells and tissue microenvironment plays a major role in cancer development, progression and metastasis. The biochemical aspect of cancer-stromal interactions, however, is less appreciated. This short review article first provides a brief summary of the communications between cancer cells and the tissue microenvironment by direct cell-cell interactions and by soluble factors, and then describes several biochemical pathways that are important for the interaction between stromal and cancer cells with respect to energy metabolism, redox balance, cell survival and drug resistance. The potential therapeutic implications of abolishing stromal protective mechanisms to overcome drug resistance are also discussed.

Entities:  

Mesh:

Year:  2011        PMID: 21191189      PMCID: PMC3230306          DOI: 10.4161/cbt.11.2.14623

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  85 in total

Review 1.  Environment-mediated drug resistance: a major contributor to minimal residual disease.

Authors:  Mark B Meads; Robert A Gatenby; William S Dalton
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

Review 2.  Apoptosis and glutathione: beyond an antioxidant.

Authors:  R Franco; J A Cidlowski
Journal:  Cell Death Differ       Date:  2009-08-07       Impact factor: 15.828

3.  Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myeloma.

Authors:  Guido Bisping; Doris Wenning; Martin Kropff; Dirk Gustavus; Carsten Müller-Tidow; Matthias Stelljes; Gerd Munzert; Frank Hilberg; Gerald J Roth; Martin Stefanic; Sarah Volpert; Rolf M Mesters; Wolfgang E Berdel; Joachim Kienast
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

Review 4.  Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.

Authors:  Vadivel Ganapathy; Muthusamy Thangaraju; Puttur D Prasad
Journal:  Pharmacol Ther       Date:  2008-11-01       Impact factor: 12.310

Review 5.  Stroma-initiated hedgehog signaling takes center stage in B-cell lymphoma.

Authors:  Ralph K Lindemann
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

6.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors:  Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

7.  Glutathione depletion and disruption of intracellular ionic homeostasis regulate lymphoid cell apoptosis.

Authors:  Rodrigo Franco; Wayne I DeHaven; Maria I Sifre; Carl D Bortner; John A Cidlowski
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

Review 8.  Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets.

Authors:  Teru Hideshima; Constantine Mitsiades; Giovanni Tonon; Paul G Richardson; Kenneth C Anderson
Journal:  Nat Rev Cancer       Date:  2007-08       Impact factor: 60.716

9.  Essential role of stromally induced hedgehog signaling in B-cell malignancies.

Authors:  Christine Dierks; Jovana Grbic; Katja Zirlik; Ronak Beigi; Nathan P Englund; Gui-Rong Guo; Hendrik Veelken; Monika Engelhardt; Roland Mertelsmann; Joseph F Kelleher; Peter Schultz; Markus Warmuth
Journal:  Nat Med       Date:  2007-07-15       Impact factor: 53.440

Review 10.  Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia.

Authors:  Vassilios I Avramis; Prakash Nidhi Tiwari
Journal:  Int J Nanomedicine       Date:  2006
View more
  20 in total

1.  Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes.

Authors:  Weiliang Chen; Donghai Wang; Xinwen Du; Ying He; Songyu Chen; Qianqian Shao; Chao Ma; Bin Huang; Anjing Chen; Peng Zhao; Xun Qu; Xingang Li
Journal:  Med Oncol       Date:  2015-01-29       Impact factor: 3.064

Review 2.  The impact of non-genetic heterogeneity on cancer cell death.

Authors:  Zintis Inde; Scott J Dixon
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-12-18       Impact factor: 8.250

3.  Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC.

Authors:  Wei Liu; Anne Le; Chad Hancock; Andrew N Lane; Chi V Dang; Teresa W-M Fan; James M Phang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

4.  Generation and functional assessment of 3D multicellular spheroids in droplet based microfluidics platform.

Authors:  P Sabhachandani; V Motwani; N Cohen; S Sarkar; V Torchilin; T Konry
Journal:  Lab Chip       Date:  2016-02-07       Impact factor: 6.799

5.  Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.

Authors:  Timothy R Wilson; Jane Fridlyand; Yibing Yan; Elicia Penuel; Luciana Burton; Emily Chan; Jing Peng; Eva Lin; Yulei Wang; Jeff Sosman; Antoni Ribas; Jiang Li; John Moffat; Daniel P Sutherlin; Hartmut Koeppen; Mark Merchant; Richard Neve; Jeff Settleman
Journal:  Nature       Date:  2012-07-26       Impact factor: 49.962

6.  The Prognostic Implications of FIX and FLO Patterns in Mucinous Colon Carcinomas.

Authors:  Sulen Sarioglu; Guray Akturk; Selman Sokmen; Hulya Ellidokuz; Aras Emre Canda; Mehtat Unlu; Abdullah Haluk Sirin; Ozgul Sagol; Cem Terzi; Mehmet Fuzun
Journal:  J Gastrointest Cancer       Date:  2019-06

7.  Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells.

Authors:  Xianhui Wang; Jason Wong; Christopher J Sevinsky; Leila Kokabee; Faiza Khan; Yan Sun; Douglas S Conklin
Journal:  Mol Cancer Ther       Date:  2016-06-02       Impact factor: 6.261

8.  Tumor-stroma relationships: who's the driver?

Authors:  Richard F Wooster
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

9.  The EMILIN/Multimerin family.

Authors:  Alfonso Colombatti; Paola Spessotto; Roberto Doliana; Maurizio Mongiat; Giorgio Maria Bressan; Gennaro Esposito
Journal:  Front Immunol       Date:  2012-01-06       Impact factor: 7.561

10.  Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines.

Authors:  Cornel Joseph Phillip; Shadia Zaman; Shujun Shentu; Kumudha Balakrishnan; Jiexin Zhang; Veera Baladandayuthapani; Pietro Taverna; Sanjeev Redkar; Michael Wang; Christine Marie Stellrecht; Varsha Gandhi
Journal:  J Hematol Oncol       Date:  2013-12-10       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.